| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.092 | 0.06 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.07 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.094 | 0.07 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.07 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |